Laboratory Corporation of America Holdings (LH)

207,94 -0,03 (-0,01%) Alla chiusura: 04:00PM EDT

Laboratory Corporation of America Holdings

358 South Main Street
Burlington, NC 27215
United States
336 229 1127
https://www.labcorp.com

Settore/i: Healthcare
Settore: Diagnostics & Research
Impiegati a tempo pieno: 56.950

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Adam H. Schechter	President, CEO & Chairman	4,66M	N/D	1965
Mr. Glenn A. Eisenberg	CFO & Executive VP	1,87M	N/D	1961
Mr. Mark S. Schroeder	Executive VP, President of Diagnostics Laboratories & COO	1,43M	129,25k	1961
Dr. Brian J. Caveney J.D., M.D., M.P.H.	EVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer	1,3M	N/D	1974
Ms. Anita Z. Graham	Executive VP & Chief Human Resources Officer	1,35M	N/D	1971
Mr. Peter J. Wilkinson	Senior VP & Chief Accounting Officer	N/D	N/D	1972
Mr. Lance V. Berberian	Executive VP and Chief Information & Technology Officer	876,62k	N/D	1963
Christin O'Donnell	Vice President of Investor Relations	N/D	N/D	N/D
Ms. Sandra D. van der Vaart	Executive VP, Chief Legal Officer, Chief Compliance Officer & Corporate Secretary	N/D	N/D	1960
Ms. Amy B. Summy	Executive VP & Chief Marketing Officer	N/D	N/D	1967

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

Laboratory Corporation of America Holdings operates as a life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was incorporated in 1994 and is headquartered in Burlington, North Carolina.

Governance aziendale

L'ISS Governance QualityScore di Laboratory Corporation of America Holdings al 1 aprile 2024 è 2. I criteri di valutazione fondamentali sono revisione: 5; Consiglio di Amministrazione: 7; diritti degli azionisti: 1; retribuzione: 2.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.